Reduction of Parenteral Nutrition in Children with Short Bowel Syndrome Treated with Teduglutide: Experience from the Czech Republic
Klinische Pädiatrie · 01.09.2026 · 238 (05) · 265-271
DOI: 10.1055/a-2646-0683 ↗Kurz gefasst
Fachartikel in der Zeitschrift Klinische Pädiatrie, erschienen am 01.09.2026. Verfasst von Sarka Peskova und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics, Motol University Hospital, Praha, Czech Republic. Hauptthemen laut MEDLINE: Short Bowel Syndrome, Peptides, Parenteral Nutrition, Home, Gastrointestinal Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Short bowel syndrome (SBS) results from a severe reduction in intestinal absorptive capacity, rendering it insufficient to meet the body's nutritional requirements. Teduglutide represents a novel therapeutic approach for patients with SBS. This study aims to share our experiences and outcomes of Teduglutide treatment in children with SBS, focusing on the development of their anthropometric parameters. This study included all pediatric SBS patients in the Czech Republic receiving home parenteral nutrition (PN) who began Teduglutide treatment from May 2019 to June 2024. We analyzed the changes in volume and caloric content of PN and anthropometric parameters for each patient. All 10 patients showed a reduction in PN volume and caloric content during Teduglutide treatment with a mean value 67%+/− 29. There was also a notable decrease in the caloric content of PN, although this did not always correlate with the volume reduction, the mean value was 52.3%+/− 40.6. Despite the reduced reliance on PN, there was a mean improvement in weight and height among the patients. Gastrointestinal complications were the most common side effects observed. Our findings confirm the positive impact of Teduglutide on intestinal absorption in pediatric SBS patients. They also validate its safety and efficacy in this population. Despite the reduction in PN, improvements in weight were evident across the entire patient cohort.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Paediatrics, Motol University Hospital, Praha, Czech Republic.
- Department of Paediatrics, University Hospital Ostrava, Ostrava, Czech Republic.
- Department of Paediatrics, University Hospital Brno Children's Hospital, Brno, Czech Republic.
- Department of Paediatrics, University Hospital Plzen, Plzen, Czech Republic.
- Department of Paediatrics, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
- Department of Paediatrics, University Hospital Olomouc, Olomouc, Czech Republic.
ORCID-Profile: Sarka Peskova
Zitieren
APA
Peskova, S., Sulakova, A., Bajerova, K., Schwarz, J., Melek, J., Karaskova, E., & Fencl, F. (2026). Reduction of Parenteral Nutrition in Children with Short Bowel Syndrome Treated with Teduglutide: Experience from the Czech Republic. Klinische Pädiatrie, 238(05), 265-271. https://doi.org/10.1055/a-2646-0683
Vancouver
Peskova S, Sulakova A, Bajerova K, Schwarz J, Melek J, Karaskova E, et al. Reduction of Parenteral Nutrition in Children with Short Bowel Syndrome Treated with Teduglutide: Experience from the Czech Republic. Klinische Pädiatrie. 2026;238(05):265-271. doi:10.1055/a-2646-0683
BibTeX
@article{Peskova2026,
author = {Peskova, Sarka and Sulakova, Astrida and Bajerova, Katerina and Schwarz, Jan and Melek, Jan and Karaskova, Eva and Fencl, Filip},
title = {Reduction of Parenteral Nutrition in Children with Short Bowel Syndrome Treated with Teduglutide: Experience from the Czech Republic},
journal = {Klinische Pädiatrie},
year = {2026},
volume = {238},
number = {05},
pages = {265--271},
doi = {10.1055/a-2646-0683}
}
EUVIMED